Macrocystic serous cystadenoma of the pancreas: a morphologic variant differing from microcystic adenoma

K Lewandrowski1, A Warshaw, C Compton

  • 1Department of Pathology, Massachusetts General Hospital, Boston, 02114.

Human Pathology
|August 1, 1992
PubMed

Insights

Macrocystic serous cystadenoma of the pancreas, often overlooked, presents differently than microcystic adenoma. These benign pancreatic neoplasms are morphologic variants, suggesting a unified "serous cystadenoma" classification.

Area of Science:

  • Gastroenterology
  • Surgical Pathology
  • Diagnostic Imaging

Background:

  • The term "microcystic adenoma" is widely accepted for a specific pancreatic tumor.
  • Macrocystic variants of serous cystadenoma have been poorly documented in existing literature.

Observation:

  • This study reports five cases of macrocystic serous cystadenoma, including two unilocular types.
  • These tumors displayed macroscopic features distinct from microcystic adenoma, posing diagnostic challenges.
  • Computed tomography scans incorrectly suggested mucinous cystic neoplasms or pseudocysts in all cases.

Findings:

  • Two out of three cases with intraoperative frozen sections were misclassified.
  • Macrocystic and microcystic serous tumors are proposed as morphologic variants of the same benign neoplasm.
  • Diagnostic difficulties arose for radiologists and pathologists due to differing macroscopic appearances.

Implications:

  • The findings suggest that "serous cystadenoma" should encompass all variants, including macrocystic and microcystic types.
  • Accurate classification is crucial for appropriate patient management and treatment strategies.
  • Further research into the distinct imaging and pathological features of these variants is warranted.